Jan 11, 2023 / 01:15AM GMT
Casey Rene Woodring - JPMorgan Chase & Co, Research Division - Research Analyst
All right. Great. Thank you, everybody. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to introduce our next company, ICON Plc. I'm pleased to be joined today by CFO, Brendan Brennan; and CFO (sic) [CEO], Steve Cutler. They're going to do a presentation followed by a Q&A session afterwards, where you'll be able to ask a question in person or via the webcast.
So with that, I'll turn it over to Steve.
Steven A. Cutler - ICON Public Limited Company - CEO & Director
Thanks, Casey, and welcome to everyone. Thank you to JPMorgan for the opportunity to present here this afternoon or this evening. Casey's mentioned Brendan Brennan, my CFO, who's joined me on stage. Brendan is the one with the tie on, I think the only one with a tie on in this room. And Kate Haven, our VP of IR, is sitting over the table over here.
So this is a presentation around ICON. We believe we are one of the, if not the strongest
ICON PLC at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot